News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CombiMatrix Corporation (CBMX) Reports Results for 2012 Third Quarter


11/7/2012 9:18:42 AM

IRVINE, Calif., Nov. 7, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, reported today that total revenues for the third quarter and first nine months of 2012 increased to $1.3 million and $3.9 million, respectively, up 5 percent and 14 percent from the third quarter and first nine months of 2011. Revenues from the Company's core prenatal testing markets in the third quarter grew by 73 percent over the corresponding period in 2011 and grew by more than 76 percent in the first nine months of 2012 over the comparable prior year period. The Company performed a total of 1,356 billable diagnostic tests for 110 customers in the third quarter of 2012, compared to 1,157 tests for 101 customers in the third quarter of 2011.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES